Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02261597 · ClinicalTrials.gov registry record

Challenging the Inflammatory Response System in Insomnia Disorder

A clinical trial of Insomnia, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
44
Enrollment target
1
Study location

NCT02261597 is a study of Insomnia that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 44 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02261597, a study of Insomnia, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
44 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to understand how insomnia (compared to good sleep) may affect the response of the body to a repeated physiological challenge, such as inserting the hand in ice-cold water for several times in a row. In particular, the investigators are interested in the response of markers that can be associated with stress, such as blood pressure and stress hormones.

Conditions Studied

Interventions

  • BEHAVIORAL Cold Pressor Test

Study Locations (1)

Massachusetts

  • BIDMC - Boston

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2015-01
Est. Completion 2018-03

What the Registry Record Tells You About NCT02261597

The ClinicalTrials.gov registry entry for NCT02261597 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (74% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Cold Pressor Test is the first listed.

NCT02261597 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02261597 about?

NCT02261597 is a clinical study titled "Challenging the Inflammatory Response System in Insomnia Disorder". The main purpose of this study is to understand how insomnia (compared to good sleep) may affect the response of the body to a repeated physiological challenge, such as inserting the hand in ice-cold water for several times in a row. In particular, the investigators are interested in the response of...

What is the current status of trial NCT02261597?

This trial is currently completed. The enrollment target is 44 participants. The study started on 2015-01. Estimated completion is 2018-03.

What conditions does trial NCT02261597 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT02261597?

The interventions under investigation include: Cold Pressor Test (BEHAVIORAL).

Who is sponsoring clinical trial NCT02261597?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02261597 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.